5-Bromo - 4 - chloro - 3-indolyl beta - D - ribofuranoside,>=98,0% (HPLC)

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Evaluation of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria

Legal Information

Supplied by Glycosynth Limited, U.S. Patent No. 7,323,488, European Patent Nos. 1436411 and 1438424, for use only in internal research conducted by the purchaser. No rights under the aforementioned patents are conveyed which permit the resale, transfer, or use for purposes other than research. Rights under the aforementioned patents, for purposes other than internal research, may be obtained by contacting Glycosynth Limited.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.